Novo Nordisk says hackers stole clinical trial data
Novo Nordisk reports cyberattack as UK gives Wegovy pill the nod
Clinical trial participant data stolen, but pharma giant says exposed records were pseudonymized
Pharmaceutical giant Novo Nordisk says data related to clinical trial participants was stolen as part of a cyberattack.
The affected patient data was pseudonymized and not directly linked to names or other direct identifiers, the company said.
The maker of the Wegovy weight-loss drug said the affected data types include patient ID, information on trial participation, gender, year of birth, biomarkers, health/immunogenicity data, and lifestyle factors including smoking status, alcohol use, and BMI.
"This information is not directly linked to any patients by name or other direct identifiers," the Novo Nordisk said on its dedicated page for the attack.
"Information about identity would therefore require access to underlying information, identifying patients by name etc. This information was not exposed. We therefore do not consider the incident...
Copyright of this story solely belongs to theregister.com. To see the full text click HERE